Revised Haryana EML Total Drugs = 284 Total Components ... lists... · mg/ml for Spinal Anaesthesia Injection ... 10 ml amp GH CHC IPD LP ... Magnesium sulphate For use in eclampsia

Sr. No. Medicines Dosage Forms Strength

GH CHC PHC/UD Sub centre OPD IPD OT RC LP

1 1 Halothane Inhalation

3% to 5% in

oxygen/Nitrous Oxide.

Maint 0.5-1%,(250ml)

GH OT RC

2 2 Ketamine Injection, (as hydrochloride) 50 mg /ml,10 ml vial GH CHC OT RC

3 3 Nitrous oxide Inhalation GH OT LP

4 4 Oxygen Inhalation (medicinal gas) GH CHC PHC Sub centre OT LP

5 5 Thiopentone Injection (sodium) Powder 0.5 g GH OT RC

6 6 Midazolam Injection 1 mg/ml GH CHC OT RC

7 7 Propofol Injection1% vial (10mg/ml ,10

ml vial)GH OT RC

8 8

*Isoflurane

*Purchase in small quantity &

prescription has to be

monitored

Inhalation 100 ml GH OT RC

9 9 Fentanyl Injection 25 mcg/ml(2ml) GH OT RC

Category Usage

1. ANAESTHETICS

1.1 General anesthetics and oxygen

Revised Haryana EML

Total Drugs = 284

Total Components = 428

* All the drugs to be dispensed in OPD will be made available in IPD as and when required.

* All drugs in OPD,IPD should be made available in OT as and when required.

* The column IPD combines the drugs to be made available at different work stations of the hospital like wards,injection room,Labour Room, emergency

department,ICU,SNCU,minor OT or any other.



Category Usage

10 10 Sevoflurane Inhalation 250 ml GH OT RC

11 11 Bupivacaine For epidural &

local anesthesia Injection (hydrochloride) 0.5% 5 ml ampoule GH CHC OT RC

12 12

Bupivacaine heavy 5 mg with

Dextrose Monohydrate 80

mg/ml for Spinal Anaesthesia

Injection5 mg + 80 mg/ml,4 ml

ampouleGH CHC OT RC

13 Jelly sterile 2%, 30 gm GH CHC PHC IPD RC

14 Jelly sterile 5% 20 gm GH CHC PHC IPD RC

15 Injection 2%, 30 ml vial GH CHC PHC Sub centre IPD RC

16 Injection ( Heavy) 2%, 2 ml vial GH CHC OT LP

17 Injection 4%, 30 ml vial GH OT LP

14 18 Lignocaine Hydrochloride +

AdrenalineInjection

2% + Adrenaline

1:80,000, 30 ml vialGH CHC PHC IPD RC

19 Injection (sulphate) 0.5 mg/ml, 1 ml

ampouleGH CHC PHC IPD OT RC

20 Injection (sulphate) 0.5 mg/ml, 20 ml

ampouleGH IPD OT RC

16 21 Glycopyrolate Injection0.2 mg/ml 1 ml

ampouleGH IPD RC

17 22 Diazepam Injection 5 mg/ml, 2 ml

ampoule GH CHC PHC IPD RC

23 Tablet (sodium) 50 mg GH CHC PHC Sub centre OPD RC

24 Injection25 mg/ml, 3 ml

AmpouleGH CHC PHC IPD RC

25 Gel 1% GH CHC PHC OPD RC

2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)

18 Diclofenac

15 Atropine.

2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE

MODIFYING AGENTS IN RHEUMATOID DISORDERS (DMARDs)

1.2 Local anaesthetics

13 Lignocaine Hydrochloride

1.3 Preoperative medication and sedation for short-term procedures



Category Usage

19 26Diclofenac Sodium 50 mg +

Paracetamol 325 mg TabTablet 50 mg + 325 mg GH CHC PHC OPD RC

27 Tablet 200 mg GH CHC PHC OPD RC


21 29 Thiocolchicoside Tablet 4mg GH CHC OPD RC

30 Tablet 500 mg GH CHC PHC Sub centre OPD RC

31 Suspension 125 mg/5ml,60 ml GH CHC PHC Sub centre OPD RC

32 Injection150 mg/ml,2 ml

ampouleGH CHC PHC IPD RC

33 Drops 150 mg/ml GH CHC PHC OPD RC

23 34 Aceclofenac 100mg Tablet 100 mg GH CHC PHC OPD RC

35 Tablet 10 mg GH IPD RC

36 Injection10 mg/ml, 1ml

ampouleGH IPD RC

37 Tablet 50 mg GH CHC OPD RC

38 Injection50 mg/ml 2 ml

ampouleGH CHC IPD RC

26 39

*Pentazocine lactate



monitored

Injection25 mg/ml, 1 ml

AmpouleGH CHC PHC IPD RC

27 40

*Pethidine Hydrochloride



monitored

Injection50 mg/ml,1 ml

ampouleGH IPD RC

28 41 Allopurinol Tablet 100 mg GH CHC PHC OPD LP

29 42 Hydroxy Chloroquine Tablet (Sulfate) 200 mg GH CHC OPD RC

30 43 Sulfasalazine Tablet 500 mg GH OPD RC

31 44 Methotraxate Tablet 2.5 mg GH OPD RC

2.3 Medicines used to treat gout

2.4Disease modifying agents used in rheumatoid disorders (DMARDs)

2.2 Opioid analgesics

24

Morphine

Sulphate/Hydrochloride



monitored

25 Tramadol Hydrochloride

20 Ibuprofen

22 Paracetamol



Category Usage


46 Suspension 5 mg/ml,60 ml GH CHC PHC Sub centre OPD RC

47 Drops 10mg/ml GH OPD RC

33 48 Chlorpheniramine Tablet (hydrogen maleate) 4 mg GH CHC PHC Sub centre OPD RC

34 49 Pheniramine maleate Injection 22.75 mg/ml,2 ml GH CHC PHC Sub centre IPD RC



36 52 Dexamethasone Injection (disodium) 4 mg/ml,2 ml ampoule GH CHC PHC Sub centre IPD RC

37 53 HydrocortisonePowder for injection

(sodium succinate) 100 mg vial GH CHC PHC Sub centre IPD RC



56 Suspension 5mg/5ml, 60 ml GH OPD RC

39 57 Methyl Prednisolone Injection 1 gm vial GH IPD LP

40 58 Adrenaline Injection 1 mg/ml (1:1000) ( 1

ml ampoule) GH CHC PHC IPD LP

59 Tablet 250 mg GH IPD LP

60 Tablet 500 mg GH IPD LP

42 61 Antisnake venom(polyvalent

solution)Injection 10 ml vial GH CHC PHC IPD RC

43 62Antisnake venom (polyvalent

solution)(Dry Powder)Injection 10 ml vial GH CHC PHC IPD RC

44 63 Calcium gluconate Injection 100 mg/ml, 10 ml amp GH CHC IPD LP

45 64 Naloxone Injection (hydrochloride) 400 mcg,1ml ampoule GH IPD LP

46 65 Pralidoxime (PAM) Injection 1 gm vial GH CHC IPD LP

3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS

4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING

4.1 Non-specific

41 Charcoal activated

38 Prednisolone

There is no evidence for complete clinical similarity between prednisolone and dexamethasone at high doses

32 Cetrizine

35 Hydroxyzine

4.2 Specific



Category Usage

47 66 Disodium Edetate Injection150 mg/mL ,2ml

ampouleGH IPD LP

48 67 Penicillamine Capsule/Tablet 250 mg GH IPD LP

49 68 Deferiprone (Iron Chelator) Tablet/capsule 250 mg GH IPD LP

69 Tablet 100 mg, GH CHC PHC OPD RC


71 Suspension 20 mg/ml GH CHC PHC OPD RC

72 Injection 2 mg/ml 2 ml ampoule GH CHC IPD RC



52 75

Magnesium sulphate For use

in eclampsia and severe pre-

eclampsia and not for other

convulsant disorders

Injection500mg/ml,1ml

ampouleGH CHC PHC Sub centre IPD RC



78 Suspension 20 mg/ 5 ml GH CHC PHC OPD RC

79 Injection 200 mg/ ml GH CHC PHC IPD RC

80 Tablet (sodium) 100 mg GH CHC PHC OPD RC

81 Suspension 100 mg/ 5 ml GH CHC PHC OPD RC

82 Injection (sodium) 50 mg/ml GH CHC PHC IPD RC

83Enteric coated tablet

(sodium) 200 mg GH CHC OPD RC

84Enteric coated tablet

(sodium) 500 mg GH OPD RC

85 Tablet 250 mg GH OPD RC


57 87 Clobazam Tablet 10 mg GH OPD LP

51 Lorazepam

53 Phenobarbitone

4.2 Specific (Complementary)

5. ANTICONVULSANTS/ANTIEPILEPTICS

50 Carbamazepine

56Divaloprex Sodium equivalent

to Valproic Acid

54 Phenytoin

55 Sodium valproate/Valproic

acid



Category Usage

88 Chewable tablet 400 mg GH CHC PHC Sub centre OPD RC

89 Suspension 200 mg/5 ml GH CHC PHC Sub centre OPD RC

59 90 Ivermectin Tablet 6 mg GH OPD RC

91 Capsule (anhydrous) 250 mg, GH CHC PHC OPD RC

92 Capsule (anhydrous) 500 mg GH CHC PHC OPD RC

93 Dispersible Tablet 125 mg GH CHC PHC OPD RC

94 Tablet 500 mg + 125 mg GH CHC OPD RC

95 Injection 1gm + 200 mg GH CHC IPD RC

96 Injection 250 mg + 50 mg GH CHC IPD RC

97 Injection 500 +100 mg GH IPD RC

98 Dispersible Tablet 200 mg +28.5 mg GH CHC OPD RC

62 99 Ampicillin Injection powder (sodium) 500 mg GH CHC PHC IPD RC

100 Injection powder (penicillin) 6 lacs IU vial GH IPD RC

101 Injection powder 12 lacs IU vial GH IPD RC

102 Injection powder 24 lacs IU vial GH IPD RC



105 Dispersible Tablet 50 mg GH CHC PHC OPD RC



108 Syrup 125mg/ 5 ml,30ml GH CHC PHC Sub centre OPD RC

109 Drops 100 mg/ ml GH OPD RC

6.1 Antihelminthics

6.1.1 Intestinal anthelminthics

58 Albendazole

6. ANTI-INFECTIVE MEDICINES

61 Amoxicillin + clavulanic acid

63 Benzathine penicillin

6.1.2 Antifilarials

6.2 Antibacterial

6.2.1 Beta Lactam medicines

60 Amoxicillin

64 Cefixime

65 Cefadroxil



Category Usage

110 Injection powder 250 mg GH IPD LP

111 Injection powder 1 g vial GH IPD LP

112 Injection 250mg GH CHC PHC IPD RC

113 Injection 1 gm GH CHC PHC IPD RC

114 Injection 500 mg GH IPD RC

115 Injection powder 250 mg GH CHC PHC IPD RC

116 Injection powder 1 g vial GH CHC PHC IPD RC

117 100 mg,/2 ml GH CHC PHC IPD RC

118 500 mg/2 ml GH CHC PHC IPD RC

119 250 mg/2 ml GH CHC PHC IPD RC



122 Tablet 1 gm GH OPD RC

123 Suspension 200 mg/5 ml,15ml GH CHC PHC OPD RC

71 124 Levofloxacin Tablet 500 mg GH OPD RC

72 125

Ofloxacin*

To be used rationally so as to

retain its senstivity as

antitubercular agent.

Tablet 200 mg GH CHC PHC OPD RC

6.2.1 Beta Lactam Medicines(Complementary)

66 Ceftazidime (pentahydrate)

67 Cefotaxime

70 Azithromycin

68 Ceftriaxone Powder (sodium)

6.2.2 Other antibacterial

69 Amikacin Injection



Category Usage

126 Tablet (hydrochloride) 250 mg GH CHC PHC OPD RC


128 Injection IV 200 mg/ 100 ml GH CHC PHC IPD RC

74 129 Ciprofloxacin +Tinidazole Tablet 500 mg + 600 mg GH CHC PHC OPD RC

75 130 Doxycycline Capsule (hydrochloride) 100 mg GH CHC PHC OPD RC


132 Oral suspension powder 125 mg/5 ml,30ml GH OPD RC

77 133 Gentamycin Injection (sulphate) 40 mg/ ml, 2 ml vial GH CHC PHC IPD RC



136 Injection 500 mg/ 100ml GH CHC PHC IPD RC

137 Suspension 200 mg/50 ml GH CHC PHC OPD RC

138 Tablet 100 mg +20 mg GH CHC PHC Sub centre OPD RC

139 Tablet 800 mg + 160 mg GH CHC PHC OPD RC

140 Pessaries 200 mg GH CHC PHC Sub centre OPD RC

141 Cream 2%,30 gm GH CHC PHC OPD RC

142 Solution 1% w/v,15ml GH CHC PHC OPD RC

143 Capsule/Tablet 150 mg GH CHC PHC OPD RC

144 Capsule/Tablet 200mg GH OPD RC

145 Dispersible Tablet 50 mg GH OPD RC

82 146 Griseofulvin Tablet 250 mg GH OPD LP



76 Erythromycin Base

78 Metronidazole

73

Ciprofloxacin

Final selection depends on

indication for use

81 Fluconazole

6.4 Antiviral medicines(Antiherpes medicines)

83 Acyclovir

79Sulfamethoxazole +

trimethoprim (Cotrimoxazole)

6.3 Antifungal medicines

80 Clotrimazole



Category Usage

84 149 Tinidazole Tablet 500 mg GH CHC PHC OPD RC

85 150 Flunarazine Tablet 10 mg GH OPD RC

151 Tablet 100 mg + 10 mg GH OPD LP

152 Tablet 250 mg +25 mg GH OPD LP

87 153 Trihexyphenidyl Tablet (hydrochloride) 2 mg GH OPD RC

88 154 Bromocriptine Tablet (mesylate) 2.5 mg GH OPD LP

155 Ferrous salt Tablet Equivalent to 100 mg

elemental ironGH OPD RC

156 Ferrous salt (sulphate) Oral solution Equivalent to 25 mg

iron /mlGH OPD RC

157 Ferrous salt (Iron sucrose) Injection 20mg/ml GH IPD RC

158Ferrous salt (Iron sorbitol

citric acid complex)Injection 100 mg/ ml GH IPD RC

8. ANTIPARKINSONISM MEDICINES(Complementary)

9. MEDICINES AFFECTING THE BLOOD

9.1 Antianaemia medicines

89

6.5 Antiprotozoal medicines

7 ANTIMIGRAINE MEDICINES FOR ACUTE ATTACK

8. ANTIPARKINSONISM MEDICINES

86 Levodopa + Carbidopa



Category Usage

159 Tablet

Equivalent to 60 mg

iron + 400 mcg folic

acid

GH CHC PHC Sub centre OPD RC

160 Tablet Large

Equivalent to 100 mg


acid


161 Tablet Medium

Equivalent to 45 mg


acid


162 Tablet Small

Equivalent to 20 mg


acid


163 Syrup

Equivalent to 100 mg

elemental iron + 500

mcg folic acid per 5 ml


164 Drops GH OPD RC

91 165 Folic acid Tablet 5mg GH CHC PHC Sub centre OPD RC

92 166 Heparin sodium Injection 5000 IU/ ml GH IPD LP



169 Injection 250 mg/2 ml GH CHC PHC IPD RC

170 Tablet 2 mg GH OPD LP

171 Tablet 5 mg GH OPD LP

95 172 LMW Heparin Injection (LMW) GH IPD RC

17310 mg/ml, 1 ml

ampoule, GH CHC PHC Sub centre IPD RC

1741 mg/0.5 ml water

based single doseGH CHC PHC IPD RC

90 Ferrous sulphate + Folic acid

9.2 Medicines affecting Coagulation(Complementary)

96 Menadion Sodium Bisulphite Injection

9.2 Medicines affecting coagulation

93 Ethamsylate

94 Warfarin (sodium)



Category Usage

97 175Protamine sulphate (Heparin

Antagonist)Injection

10 mg/ml, 5-ml

ampouleGH IPD LP

98 176

Purified Freeze – Dried

Human Coagulation Factor

VIII, Virus inactivated

Injection 250 IU GH IPD OT RC

99 177 Plasma Volume Expander Injection 500ml GH CHC PHC Sub centre IPD RC

100 178 Atenolol Tablet 50 mg GH CHC PHC OPD RC



181 Injection 5 mg/ml GH IPD RC

182 Tablet (sublingual) 500 micrograms GH CHC PHC IPD RC

183 Glycerine trinitrate SR 0.5 mg GH IPD RC

184 Injection (Nitro Glycerine) 5 mg/ ml GH IPD RC

185 Tablet 5 mg GH CHC PHC IPD RC

186 Tablet 20 mg (SR) GH CHC PHC IPD RC

104 187 Isosorbide dinitrate Tablet (sublingual) 5 mg GH CHC PHC IPD RC



106 190 Carvediolol Tablet 3.125 mg GH OPD RC

191 Tablet 10 mg GH CHC PHC OPD LP

192 Tablet 40 mg GH CHC PHC OPD LP

108 193 Adenosine (Phosphate) Injection 3 mg/ ml GH IPD RC

109 194 Amiodarone Tablet 100 mg GH IPD LP

110 195 Digoxin Tablet 0.25 mg GH CHC OPD RC

111 196 Verapamil Tablet 40 mg GH IPD LP

102 Glycerine trinitrate

103 Isosorbide mononitrate

10. BLOOD PRODUCTS AND PLASMA SUBSTITUTES

11. CARDIOVASCULAR MEDICINES

11.1 Antianginal medicines

101 Diltiazem

11.2 Antiarrhythmic medicines

105 Metoprolol

107 Propranolol



Category Usage



113 199 Enalapril Maleate Tablet 5 mg GH CHC PHC OPD RC

114 200 Hydrochlorothiazide Tablet 25 mg GH CHC PHC OPD RC

115 201 Methyldopa Tablet 250 mg GH CHC PHC OPD RC

116 202 Losartan HCL Tablet 50 mg GH CHC PHC OPD RC

203 Capsule(Sublingual) 5 mg GH IPD LP

204 Tablet (SR) 20 mg GH OPD RC

205 Tablet 2.5 mg GH OPD RC


207 Injection 20 mg GH IPD LP


120 209 Telmisartan HCL Tablet 40mg GH OPD RC

121 210 Dobutamine Injection 125 mg/ 5 ml GH IPD LP

122 211 Dopamine Injection (hydrochloride)40 mg/ ml in 5ml

AmpouleGH CHC IPD LP



124 214 Clopidogrel Tablet 75 mg GH CHC OPD RC

125 215 Streptokinase Injection powder 1500000 IU GH IPD RC



218 Injection 500 mg/5 ml GH CHC IPD RC


128 220 Mephentermine Injection 30 mg/ml GH OT RC

117 Nifedipine

118 Ramipril

11.3 Antihypertensive medicines

112 Amlodipine

123 Acetylsalicylic acid

11.6 Thrombolytic

126 Atorvastatin

119 Labetolol

Methyldopa & Labetalol is listed for use in the management of pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not

recommended in view of the availability of more evidence of efficacy and safety of other medicines.

11.4 Medicines used in heart failure

11.5 Antithrombotic medicines

11.7 Anti Fibrinolytic & Presser Agent

127 Tranexanemic Acid



Category Usage

129 221 Miconazole Cream (nitrate) 2%,15gm GH CHC PHC OPD RC

130 222 Clindamycin Cream 1% w/w,10gm GH OPD RC

131 223 Clobetasol + Gentamycin Ointment 0.05% + 0.1 %, 5gm GH CHC PHC OPD RC

132 224 Trichloroacetic Acid Crystal GH OT LP

133 225 Permethrin (Only for scabies) Cream 5%, 30 gm GH CHC PHC OPD RC

134 226 Acyclovir Cream 5% GH OPD RC

227 Aqueous solution 1 : 10 000 GH CHC PHC IPD LP

228 Crystal 100 gm GH CHC PHC IPD LP

136 229 Silver sulfadiazine Cream 1%,250mg GH CHC PHC Sub centre OPD RC

137 230 Betamethasone Cream (Dipropionate) 0.1% GH CHC PHC OPD RC

138 231 Calamine lotion Lotion 8% GH CHC OPD RC

139 232 Fluticasone Ointment 0.005% GH OPD RC

140 233 Momaetasone Furoate Lotion 0.1%, 15 ml GH OPD RC

141 234 Fluocinolone Acetonide Ointment 0.1% GH OPD RC

142 235 Benzoyl Per Oxide Gel 2.5%, 10 gm GH OPD RC

236 Lotion 1%, 100 ml GH CHC PHC Sub centre OPD RC

237 Cream 1%, 25 gm GH CHC PHC Sub centre OPD RC

144 238 Hydrogen Peroxide Solution 1% GH CHC PHC OT RC

145 239 Cetrimide Solution 20% conc. for dilution GH CHC PHC OT RC

12.1 Antifungal medicines

12.1 Skin(Complementary)

12.2 Anti-infective medicines

135 Potassium permanganate

12. DERMATOLOGICAL MEDICINES (topical)

13. DISINFECTANTS AND ANTISEPTICS

13.1 Antiseptics

12.3 Anti-inflammatory and antipruritic medicines

12.4 Medicines affecting skin differentiation and proliferation

12.5 Scabicides and pediculicides

143Gamma Benzene

Hexachloride



Category Usage

146 240 Chlorhexidine Solution 5% conc. for dilution GH CHC PHC Sub centre OT RC

241 Solution 5%,500ml, GH CHC PHC Sub centre OT RC

242 Solution 10%, 500 ml GH OT RC

243 Solution 5%,5 litre GH CHC PHC OT RC

244 Ointment 5%,15gm GH CHC PHC Sub centre IPD RC

245 Ointment 5%,250 gm GH CHC PHC Sub centre OPD RC

246 Scrub 7.5%, 500 ml GH CHC PHC Sub centre IPD RC

247 Cream 1%, 100 gm GH IPD RC

248 Cream 1 % 20gm GH CHC PHC OPD RC

149 249 Bleaching powder Powder GH CHC PHC Sub centre OT RC

150 250 Glutraldehyde Solution 2% / 2.4% GH CHC IPD RC


252 Injection10 mg/ml 2-ml

ampouleGH CHC PHC IPD RC

152 253 Mannitol Injectable solution 20%, 350 ml GH CHC IPD RC

153 254 Spironolactone Tablet 25 mg GH OPD RC

154 255 Tamsulosin Hydrochloride Tablet 0.4 mg GH CHC OPD RC

155 256 Tamsulosin + Dutasteride Tablet 0.4 mg + 0.5 mg GH OPD RC

156 257 Flavoxate Hydrochloride Tablet 200 mg GH CHC OPD RC

157 258 Disodium Hydrogen Citrate Suspension 1.38 gm/100 ml GH CHC PHC OPD RC

158 259 Sodium Bicarbonate Injection 7.5% GH CHC PHC IPD LP

13.1 Antiseptics(Complementary)

148 Framycetin

13.2 Disinfectants

147 Povidone iodine

14.2 Medicines for BPH

14.3 Alkalising Solution

14.3 Alkalising(Complementary)

14. MEDICINES FOR UROLOGY

14.1 Diuretics

151 Furosemide



Category Usage

260 Chewable Tablet 250 mg +250 mg + 25

mgGH CHC PHC OPD RC

261 Oral suspension300 mg+ 150 mg+ 40

mg/ 5 ml, 180 mlGH CHC PHC OPD RC

160 262

Aluminium hydroxide +

magnesium hydroxide +

Simethicone + magnesium

Carbonate

Chewable Tablet 240 mg+100 mg+25

mg +60 mg GH CHC PHC OPD RC

161 263 Omeprazole Capsule 20 mg GH CHC PHC OPD RC

264 Tablet (HCL) 150 mg GH CHC PHC Sub centre OPD RC

265 Injection 25 mg/ml in 2-ml amp GH CHC PHC IPD RC


267 Suspension 1 mg/ ml, 30ml GH CHC PHC Sub centre OPD RC

164 268 Cinnarizine Tablet 25 mg GH CHC PHC OPD RC

269 Tablet (Hydrochloride) 10 mg GH CHC PHC OPD RC

270 Injection (hydrochloride) 5 mg/ ml in 2-ml amp GH CHC PHC IPD RC


272 Injection 12.5 mg/ml GH IPD RC

15. GASTROINTESTINAL MEDICINES

15.1 Antacids and other antiulcer medicines

159

Aluminium hydroxide +

magnesium hydroxide +

Simethicone

165 Metoclopramide

166 Prochlorperazine

162 Ranitidine

15.2 Antiemetic medicines

163 Domperidone



Category Usage



275 Injection 2 mg/ ml 2ml ampoule GH CHC PHC IPD RC


277 Elixir or syrup (hcl) 5 mg/ 5 ml GH CHC PHC OPD RC

278 Injection (hydrochloride) 25 mg/ml in 2-ml amp GH CHC PHC IPD RC

169 279 Doxylamine succinate Tablet 10 mg GH CHC OPD RC

170 280

Local anaesthetic, astringent

and anti-inflammatory

medicines

Ointment or suppository GH CHC PHC OPD RC

171 281 Dicyclomine Tablet (hydrochloride) 10 mg GH CHC PHC Sub centre OPD RC

172 282Mephenamic Acid +

DicyclomineTablet 500 mg +20 mg GH CHC PHC OPD RC


284 Injection 40 mg/ 2 ml GH CHC PHC IPD RC



175 287 Bisacodyl Tablet 5 mg GH CHC PHC OPD RC

176 288 Milk of Magnesia +Liquid

ParaffinSuspension

11.25 ml + 3.75 ml/ 15

ml (50 ml Packing)GH CHC PHC OPD RC

177 289 Glycerine Saline Enema GH CHC IPD LP

290 Powder for solution As per IP GH CHC PHC Sub centre OPD RC

291 Powder for solution For 200 ml GH CHC PHC Sub centre OPD RC

292 Tablet (Sulphate) 20 mg GH CHC PHC Sub centre OPD RC

293 Suspension (Sulphate) 20 mg/5 ml GH CHC PHC Sub centre OPD RC

174 Hyoscine butyl bromide

15.5 Laxatives

15.3 Antihaemorrhoidal medicines

15.4 Antispasmodic medicines

173 Drotaverine

167 Ondansetron

168 Promethazine

179 Zinc

15.6 Medicines used in Diarrhoea

178 Oral rehydration salts



Category Usage

180 294 Glibenclamide Tablet 5 mg GH CHC PHC OPD RC

181 295 Glimipride Tablet 1 mg GH CHC OPD RC



183 298Biphasic Isophane (R-DNA

origin 30/70Injection 40 I.U/ml GH IPD RC

184 299 Insulin (soluble) Injection 40 IU/ml in 10 ml vial GH IPD RC

185 300 Intermediate-acting insulin

(Lente)Injection 40 IU/ml in 10 ml vial GH IPD RC


302 Tablet (hydrochloride) 1 gm SR GH OPD RC

187 303 Clomifene Tablet (citrate) 50 mg GH OPD RC

188 304 Medroxyprogesterone acetate Tablet 10mg GH OPD RC

189 305 Progesterone Tablet 100 mg GH OPD RC

190 306 Norethisterone Tablet 5 mg GH OPD RC

191 307 Levothyroxine Tablet (sodium) 50 mcg GH CHC PHC OPD RC

192 308 Carbimazole Tablet 5 mg GH OPD RC

193 309 Propylthiouracil Tablet 50 mg GH OPD LP

194 310Tuberculin, purified protein

derivative (PPD)Injection 2 T.U./0.1 ml GH IPD RC

16.1 Insulins and other antidiabetic

182 * Gliclazide

16. HORMONES

17.1 Diagnostic agents

All tuberculins should comply with the WHO Requirements

16.3 Progestogens

16.4 Thyroid hormones and antithyroid medicines

17. IMMUNOLOGICALS

186 Metformin

16.2 Ovulation inducers



Category Usage

311 Injection 50 mcg / vial GH CHC PHC IPD RC

312 Injection 150 mcg/vial GH IPD RC

313 Injection 300mcg/vial GH CHC PHC IPD RC

196 314 Anti Rabies Immunoglobulin Injection 3000 IU /ml GH IPD LP

197 315 Tetanus vaccine Injection 0.5 ml Ampoule GH CHC PHC Sub centre IPD RC

198 316 Hepatitis B vaccine Injection1 % vial, 10 mg/ml, 10

ml vialGH CHC PHC Sub centre IPD RC

317 Injection ID 1 ml GH CHC PHC IPD RC

318 Injection IM 0.5 ml GH CHC PHC IPD RC

200 319 Atracurium besylate Injection 10 mg/ ml GH OT RC

201 320 Succinyl Choline Vial Injection 50 mg/ml GH OT RC

202 321 Neostigmine (methyl) Injection 500 mcg/ ml in 1 ml

amp GH OT RC

203 322Vecuronium (bromide powder

)Injection

4 mg Dry Powder/

AmpouleGH OT LP

204 323 Recronium Bromide Injection 10 mg/ ml GH OT LP

205 324 Chloramphenicol Ointment 1% GH CHC PHC Sub centre OPD RC

325 Drops 0.3% GH CHC PHC Sub centre OPD RC

326 Ointment 0.3% GH OPD RC

207 327Ciprofloxacin +

Dexamethasone Eye Drops 0.3% +0.1% GH OPD RC

208 328 Acylovir Eye Oint 5%, 5 gm GH OPD LP

209 329 Tobramycin Eye drops 0.3%w/v, 5 ml GH OPD RC

17.2 Sera and immunoglobulins

18. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS

19. OPHTHALMOLOGICAL PREPARATIONS

19.1 Anti-infective agents

17.3 For specific groups of individuals

199

Anti Rabies vaccine (Chick-

Embryo/Verocell/Human

Diploid)

All plasma fractions should comply with the WHO Requirements for the Collection, Processing and Quality Control of Blood, Blood Components and

Plasma Derivatives.

195

Anti-RHO-D

Immunoglobulin(Human)

Injection (Polyclonal)

(Thiomersal Free)

206 Ciprofloxacin



Category Usage

210 330 Moxifloxacin Eye drops 0.5%w/v, 5 ml GH OPD RC

211 331 Natamycin Eye Drops 2% GH OPD LP

212 332 Prednisolone (sodium

phosphate)Eye drops 1% GH OPD RC

213 333 Flurbiprofen Eye Drop 0.03% GH OPD RC

214 334 Flouromethalone Eye drops 0.1% w/v GH OPD RC

19.4 Miscellaneous

215 335 Hyaluronidase Injection 1500 IU/ ml GH OT LP

216 336 Tryphen Blue Dye GH OT LP

217 337 Acetazolamide Tablet 250 mg GH OPD RC

218 338 Pilocarpine (hydrochloride or

nitrate)Eye drops 2% GH OPD RC

339 Eye drops 0.25% , 5 ml GH OPD RC

340 Eye drops 0.5%, 5 ml GH OPD RC

341 Drops 1% GH IPD LP

342 Ointment 1% GH IPD LP

221 343 Cyclopentolate Eye Drop 1% w/w GH IPD RC

222 344 Homatropine Eye Drops 1% GH IPD LP

223 345 Tropicamide +

Phenylepherine Eye Drops 0.8% + 5% GH IPD RC

224 346 Hydroxypropyl mehtylcellulose Injection 2% GH IPD RC

225 347 Sodium Carboxymethyl

Cellulose Eye Drops 0.5% w/v GH OPD RC

226 348 Anti Allergic Eye Drops GH CHC PHC OPD RC

227 349 Disodium Cromoglycate Eye Drops GH CHC PHC OPD RC

19.6 Mydriatics

220 Atropine (sulphate)

19.5 Miotics and antiglaucoma medicines

219 Timolol (maleate)

19.2 Anti Fungal

19.3 Anti-inflammatory agents

19.7 Lubricating

19.8 Anti Allergic

20. NASAL ENT



Category Usage

350 Drops 0.05%, GH CHC PHC OPD RC

351 Drops 0.1% GH CHC PHC OPD RC

229 352 Saline Nasal Drops 0.6% GH CHC PHC Sub centre OPD RC

230 353 Glycerin Solution 500 gm bottle GH CHC PHC OPD RC

231 354

Paradichlorbenzene +

Benzocain + Chlorbutol +

Turpentine Oil

Ear Drops2 % + 2.7 % + 5 % +

15 %GH CHC PHC OPD RC

232 355

Chloremphenicol

+Beclomethasone

dipropoinate +Clotrimazole +

lignocaine Hydrochloride HCL

Ear Drops5 % w/v + 0.025% w/v

+ 1 % w/v + 2 % w/v GH CHC PHC OPD RC

233 356 Clotrimazole Ear Drops GH CHC PHC OPD RC

357 Tablet 125 mcg GH CHC PHC Sub centre OPD RC

358 Injection200 mcg in 1 ml

ampouleGH CHC PHC Sub centre IPD RC

235 359 Oxytocin Injection 5 IU in 1 ml ampoule GH CHC PHC Sub centre IPD RC

236 360 Carboprost Injection 25 mg/ml(250 mcg) GH IPD RC

237 361 Dinoprostone Gel 0.5 mg, 3 gm GH IPD RC

238 362 Mifepristone Tablet 200 mg GH CHC OPD RC

363 Tablet 25 mcg GH IPD RC

364 Tablet 200 mcg GH CHC PHC Sub centre IPD RC



241 367 Valethemate Injection 8mg/ml GH CHC PHC IPD RC

242 368Chlorpromazine

(hydrochloride) Tablet 50 mg GH OPD RC

243 369 Fluphenazine (Decanoate) Injection 25 mg, 1 ml ampoule GH IPD RC


21.1 Oxytocics

234 Methyl ergometrine

228 Xylometazoline

21. OXYTOCICS AND ANTIOXYTOCICS

22. PSYCHOTHERAPEUTIC MEDICINES

22.1 Medicines used in psychotic disorders

244 Haloperidol

21.2 Antioxytocics

240 Isoxsuprine (hydrochloride)

21.1 Oxytocics (Complementary)

239 Misoprostol



Category Usage

371 Injection 5 mg , 1 ml ampoule GH IPD RC

245 372 Risperidone Tablet 2gm GH OPD RC

246 373 Quetiapine Tablet SR 50 mg GH OPD RC

247 374 Amitriptyline (hydrochloride) Tablet 10 mg GH CHC OPD RC

248 375 Fluoxetine (hydrochloride) Capsule 20 mg GH CHC PHC OPD RC

249 376 Sertraline Tablet (SR) 50 mg GH OPD RC

250 377 Lithium carbonate Tablet 300 mg GH OPD RC

378 Tablet 0.25 mg GH CHC PHC OPD RC


252 380 Donepezil Tablet 5 mg GH OPD RC

253 381 Clonazepam Tablet 0.5mg GH OPD RC

254 382 Bupropion Tablet 150mg GH OPD RC

255 383 Buprenorphine Tablet (Sublingual) 0.4mg GH OPD RC

256 384 Aminophylline Injection25 mg/ ml, 10 ml

ampouleGH CHC IPD LP

257 385 Ipratropium bromide –

aerosolNebulizing Solution GH IPD LP

258 386

Cough Expectorent

(Salbutamol 2 mg +

Bromhexine 4 mg)

SyrupSalbutamol 2 mg +

Bromhexine 4 mg GH CHC PHC OPD RC

387 Inhalation – aerosol 100 micrograms/ dose GH CHC PHC OPD RC

388 Suspension 2 mg/5 ml GH CHC PHC OPD RC

389Nebulizer solution

(sulphate)5 mg/ ml GH CHC PHC IPD RC

260 390Beclomethasone +

SalbutamolInhalation (MDI) GH OPD RC

244 Haloperidol

23. MEDICINES ACTING ON THE RESPIRATORY TRACT

23.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease

259 Salbutamol

251 Alprazolam

22.5 Medicines used for Deaddiction

22.2 Medicines used in depressive disorders

22.3 Medicines used in bipolar disorders

22.4 Medicines used in generalized anxiety and sleep disorders



Category Usage

391 Tablet 115 mg + 35 mg, GH CHC PHC OPD RC

392 Tablet 231 mg + 69 mg GH CHC PHC OPD RC

393 Injection169.4 mg + 56.6 mg/2

mlGH CHC PHC IPD RC

262 394 Budesonide Nebulizer solution 15 ml vial GH CHC IPD RC

395 Tablet (sulphate) 2 mg GH CHC PHC OPD RC

396 Tablet (sulphate) 4 mg GH CHC PHC OPD RC

397 Injectable solution 5%, isotonic GH CHC PHC Sub centre IPD RC

398 Injectable solution 10% isotonic GH IPD RC

399 Injectable 25% GH IPD RC

265 400 Glucose with sodium

chloride/salineInjectable solution

5% glucose + 0.9%

sodium chlorideGH CHC PHC IPD RC

266 401 Isolyte – P Injection GH CHC PHC IPD RC

267 402 Potassium chloride Injectable solution 11.2% in 20ml GH IPD RC

268 403 Ringer lactate Injectable IV solution GH CHC PHC Sub centre IPD RC

269 404 Sodium bicarbonate Injectable IV solution 7.5% GH CHC PHC IPD RC

270 405 Sodium chloride Injectable solution 0.9% isotonic GH CHC PHC IPD RC

271 406 Water for injection Injection 5ml ampoule GH CHC PHC IPD RC

272 407 Ascorbic acid Tablet 500 mg GH CHC PHC OPD RC


409 Syrup GH OPD RC

274 410 Pyridoxine HCl Tablet 10 mg GH OPD RC

275 411 Vitamin A Suspension 100000 IU/ml GH CHC PHC Sub centre OPD RC

412 Syrup GH CHC PHC OPD RC

413 Injection GH CHC PHC IPD RC

414 Drops GH CHC PHC OPD RC

277 415 B-Complex Tablet GH CHC PHC Sub centre OPD RC

276 Multi Vitamin

24.2 Miscellaneous

25. VITAMINS AND MINERALS

273 Calcium salts

24. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES

24.1 Parenteral

264 Glucose/dextrose

261 Etophylline + Theophylline

263 Salbutamol



Category Usage

416 Cholecalciferol sachets 1000 IU GH CHC PHC OPD RC

417 Drops 4000IU GH CHC PHC OPD RC

418 Tablet (Chewable) 60000 IU GH CHC PHC OPD RC


420 Injection 60 mg/ml GH CHC IPD RC

280 421 Artemether Injection 80 mg/ml, 1 ml amp GH CHC IPD RC

422 Tablet 150 mg base GH CHC PHC Sub Centre OPD RC

423 Suspension 50 mg/ 5 ml GH CHC OPD RC




283 427 Quinine (Dihydrochloride) Injection300 mg/ ml, 2ml

ampouleGH CHC IPD RC

284 428 Sulfadoxine + Pyrimethamine Tablet 500 mg + 25 mg GH CHC PHC OPD RC

281 Chloroquine (Phosphate)

282 Primaquine (Diphosphate)

26. ANTIMALARIAL MEDICINES (TO BE PROCURED AT STATE LEVEL)

279 Artesunate

278 Vitamin D

Documents

Revised Haryana EML Total Drugs = 284 Total Components ... lists... · mg/ml for Spinal Anaesthesia Injection ... 10 ml amp GH CHC IPD LP ... Magnesium sulphate For use in eclampsia